Active drainage of cardiac lymph using hyaluronidase was attempted in dogs. The results were satisfactory and the ischemic myocardium was salvaged. The infract risk area (I/R) ratio decreased after drainage.
Regional myocardial ischemia and infarction were provided by means of ligature of the left coronary artery for 120 and 240 minutes respectively. Cardiac lymph was collected by conventional procedures. Enzymes released from the myocardium increased significantly in the cardiac lymph. The volume of cardiac lymph gradually increased after ligature of the coronary artery. Administration of hyaluronidase further increased the cardiac lymph flow and significantly decreased the I/R ratio as determined by triphenyl tetrazolium chloride (TTC) and methylene blue staining. Drainage of the cardiac lymph salvaged the ischemic myocardium. Reduction of interstitial edema and augmentation of cardiac lymph flow with the hyaluronidase prevented the development of the infarction. This is the first documentation of the effect of active drainage of cardiac iymph on the development of infarction through observation of the I/R ratio.
Get full access to this article
View all access options for this article.
References
1.
Ullal SR, Kluge TH, Kerth WJ, et al: Anatomical studies on lymph drainage of the heart in dogs. Ann Surg175:305-310, 1972.
2.
Gervin CA, Hackell DB, Roe CR: Enzyme content of canine cardiac lymph during acute myocardial infarction . Surg Forum25:175-176, 1974.
3.
Taira A., Morishita Y., Arikawa K., et al: Flow velocity of cardiac lymph and contractility of the heart: An experimental study. Ann Thorac Surg23:230-234, 1977.
4.
Taira A., Yamashita M., Arikawa K., et al: Cardiac lymph in electrical ventricular fibrillation: An experimental study. Ann Thorac Surg27:144-147, 1979.
5.
Taira A., Yamashita M., Chosa N., et al: Cardiac Lymph: An experimental study in dogs with reference to cardiac surgery. Jpn J Lymphol11:1-5, 1988 (in Japanese with English abstract).
6.
Swinyard EA, Pathak MA: Locally acting drugs. In: The Pharmacological Basis of Therapeutics , ed. by Gilman AG, Goodman LS, Gilman A.New York: McMillan, 1980, pp 951-963.
7.
Ullal SR, Kluge TH, Kerth WJ, et al: Changes in cardiac lymph of dogs during and after anoxia. Ann Surg175:472-478, 1972.
8.
Oliveria JM, Carballo R., Zimmerman HA: Intravenous injection of hyaluronidase in acute myocardial infarction: Preliminary report of clinical and experimental observation. Am Heart J57:712-722, 1959.
9.
Maroko PR, Libby P., Bloor CM, et al: Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation46:430-437, 1972.
10.
Maroko PR, Davidson DMLibby P., et al: Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients. Ann Int Med82:516-520, 1975.
11.
Maclean D., Fishbein MC, Maroko PR, et al: Hyaluronidase-induced reductions of myocardial infarct size . Science194:199-200, 1976.
12.
Askenazi J. , Hillis D., Diaz PE, et al: The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. Circ Res40:566-571, 1977.
13.
Willerson JY , Powell WJ Jr, Guiney TE, et al: Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol. J Clin Invest51:2989-2998, 1972 .
14.
Szabo G., Magyar S.: Effect of hyaluronidase on capillary permeability, lymph flow and passage of dye-labelled protein from plasma to lymph. Nature182:377-379, 1958.
